Reduction in touch sensitivity and hyperinnervation in vesicant-injured rabbit eyelid by direct injection of corticotropin releasing factor

Neuroscience Letters
Andrew R Harrison, L K McLoon

Abstract

Skin injury can result in inflammatory responses and increased sensitivity to touch. Corticotropin releasing factor (CRF), when administered locally or systemically, can reduce the inflammatory and hyperalgesic processes after skin injury. However, the mechanisms that control its effects are unclear. Doxorubicin injection produced inflammation, increased sensitivity to touch and more sensitive blink responses in eyelids of adult rabbits, and local injection of CRF reduced these changes. Doxorubicin alone resulted in a significant ingrowth of nerve fibers as determined by morphometric analysis of PGP 9.5 and substance P immunohistochemistry. Treatment with CRF significantly reduced this nerve fiber ingrowth, and a CRF antagonist partially blocked this protective effect. Thus, CRF has a potent tissue protective effect when administered locally after a vesicant-induced injury, and one mechanism of action is the reduction of nerve fiber ingrowth and sensitivity of the eyelid to touch.

References

Jan 1, 1978·Plastic and Reconstructive Surgery·D G Bowers, J B Lynch
Sep 1, 1976·Cancer·R RudolphR A Pattillo
Jan 14, 1997·European Journal of Pharmacology·S G CorreaI D Bianco
Dec 22, 1999·Pain·W R Lariviere, R Melzack
Feb 16, 2002·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·L K McLoonJ D Wirtschafter
Aug 2, 2003·Nature Medicine·Christoph SteinHalina Machelska

❮ Previous
Next ❯

Citations

Dec 5, 2013·World Journal of Clinical Cases·Michelangelo BuonocoreCesare Bonezzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.